Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Cito CBC System

K-Number: K240402 · 2025-02-03

Decision Date2025-02-03
Product CodeGKZ
Advisory CommitteeHE
DecisionSubstantially Equivalent

Device Summary

Cito CBC System is a medical device manufactured by Cytochip, Inc.. It received FDA 510(k) clearance on 2025-02-03 under approval number K240402. The device is classified under product code GKZ. It was reviewed by the HE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Cito CBC System?

Cito CBC System is a medical device that received FDA 510(k) clearance on 2025-02-03. It is manufactured by Cytochip, Inc.. The 510(k) number is K240402.

When was Cito CBC System approved by the FDA?

Cito CBC System received FDA 510(k) clearance on 2025-02-03, under approval number K240402.

What company makes Cito CBC System?

Cito CBC System is manufactured by Cytochip, Inc..

What is the FDA product code for Cito CBC System?

The FDA product code for Cito CBC System is GKZ.

Related Devices (Code: GKZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.